- Pagina principale
- Analisi delle app
- LORECa
- LORECa Vs. Cleverear
LORECa vs. Cleverear Utilizzo e statistiche
LORECa is a Turkish hearing aid company, established in 1996, known for producing CE-labeled digital and analog hearing aids. They offer various models, including ITE, ITC, CIC, and BTE. With a focus on R&D, LORECa aims to enhance the quality of life for those with hearing impairments through innovative and high-quality products.
LORECa is a hearing aid company based in Turkey, known for being the sole manufacturer of CE-labeled hearing instruments in the country. The company, which began in 1996, focuses on developing, producing, and distributing both digital and analog hearing aids. LORECa is certified with EN ISO 9001:2000 and EN ISO 13485:2003, ensuring high-quality products.
LORECa's product range includes custom in-the-ear (ITE), in-the-canal (ITC), completely-in-canal (CIC), and behind-the-ear (BTE) hearing aids. The company invests heavily in research and development, particularly in hearing aid chips and algorithms, to provide innovative solutions for people with hearing loss. They also offer a range of wireless and non-wireless digital signal processor (DSP) systems for hearing aids.
Their mission is to improve the quality of life for individuals with hearing impairments through advanced technology and high-quality hearing aid products.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
Cleverear allows you to adjust audio, aux, mic, stream channel settings via a bluetooth connection for hearing aids.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
LORECaRanking a confronto con Cleverear
Confronta la tendenza di classifica LORECa nei ultimi 28 giorni rispetto a Cleverear
Rank
Nessun dato disponibile
Classifica LORECa vs. Cleverear per paese a confronto
Confronta la tendenza di classifica LORECa nei ultimi 28 giorni rispetto a Cleverear
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
LORECa VS.
Cleverear
gennaio 5, 2025